Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
BEMPEDOIC ACID
(2020)
Small molecule
ATP-citrate synthase inhibitor
Unknown
Approved
Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Hyperlipoproteinemia Type II
BEMPEDOIC ACID
×
Maximum Phase:
4
First Approval:
2020
UNII:
1EJ6Z6Q368
Molecule Type:
Small molecule
Molecular Formula:
C19H36O5
Molecular Weight:
344.49
AlogP:
4.47
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
14.0
Source:
TRIHEPTANOIN
(2020)
Small molecule
Supplement
Unknown
Approved
Unknown
TRIHEPTANOIN
×
Maximum Phase:
4
First Approval:
2020
UNII:
2P6O7CFW5K
Molecule Type:
Small molecule
Molecular Formula:
C24H44O6
Molecular Weight:
428.61
AlogP:
5.9
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
20.0
Source:
ARTESUNATE
(2020)
Small molecule
Unknown
Unknown
Approved
Malaria
ARTESUNATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
60W3249T9M
Molecule Type:
Small molecule
Molecular Formula:
C19H28O8
Molecular Weight:
384.43
AlogP:
2.6
PSA:
100.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIPRETINIB
(2020)
Small molecule
Platelet-derived growth factor receptor alpha inhibitor
Unknown
Approved
Gastrointestinal Stromal Tumors; Neoplasms
RIPRETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
9XW757O13D
Molecule Type:
Small molecule
Molecular Formula:
C24H21BrFN5O2
Molecular Weight:
510.37
AlogP:
5.67
PSA:
88.05
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BEROTRALSTAT HYDROCHLORIDE
(2020)
Small molecule
Plasma kallikrein inhibitor
Unknown
Approved
Angioedemas, Hereditary
BEROTRALSTAT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
88SH1NBL2B
Molecule Type:
Small molecule
Molecular Formula:
C30H28Cl2F4N6O
Molecular Weight:
635.49
AlogP:
5.7
PSA:
108.76
HBD:
3.0
HBA:
#RotB:
9.0
Source:
GALLIUM GA 68 GOZETOTIDE
(2020)
Small molecule
Unknown
Unknown
Approved
Unknown
GALLIUM GA 68 GOZETOTIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENFLURAMINE HYDROCHLORIDE
(2020)
Small molecule
Serotonin 1d (5-HT1d) receptor agonist
Unknown
Approved
Epilepsies, Myoclonic; Seizures
FENFLURAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
3KC089243P
Molecule Type:
Small molecule
Molecular Formula:
C12H17ClF3N
Molecular Weight:
267.72
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FLORTAUCIPIR
(2020)
Small molecule
Unknown
Unknown
Approved
Unknown
FLORTAUCIPIR
×
Maximum Phase:
4
First Approval:
2020
UNII:
J09QS3Z3WB
Molecule Type:
Small molecule
Molecular Formula:
C16H10FN3
Molecular Weight:
263.28
AlogP:
3.92
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
1.0
Source:
OZANIMOD HYDROCHLORIDE
(2020)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 modulator
Unknown
Approved
Multiple Sclerosis
OZANIMOD HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
3UPR33JAAM
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClN4O3
Molecular Weight:
440.93
AlogP:
3.63
PSA:
104.2
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PEMIGATINIB
(2020)
Small molecule
Fibroblast growth factor receptor 1 inhibitor
Unknown
Approved
Cholangiocarcinoma; Neoplasms
PEMIGATINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
Y6BX7BL23K
Molecule Type:
Small molecule
Molecular Formula:
C24H27F2N5O4
Molecular Weight:
487.51
AlogP:
3.66
PSA:
83.16
HBD:
1.0
HBA:
#RotB:
6.0
Source:
POTASSIUM BITARTRATE
(2020)
Small molecule
Unknown
Unknown
Approved
Unknown
POTASSIUM BITARTRATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
NPT6P8P3UU
Molecule Type:
Small molecule
Molecular Formula:
C4H5KO6
Molecular Weight:
188.18
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CEDAZURIDINE
(2020)
Small molecule
Cytidine deaminase inhibitor
Unknown
Approved
Myelodysplastic Syndromes
CEDAZURIDINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
39IS23Q1EW
Molecule Type:
Small molecule
Molecular Formula:
C9H14F2N2O5
Molecular Weight:
268.22
AlogP:
-1.57
PSA:
102.26
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ODEVIXIBAT
(2021)
Small molecule
Ileal bile acid transporter inhibitor
Unknown
Approved
Cholestasis, Intrahepatic; Pruritus
ODEVIXIBAT
×
Maximum Phase:
4
First Approval:
2021
UNII:
2W150K0UUC
Molecule Type:
Small molecule
Molecular Formula:
C37H48N4O8S2
Molecular Weight:
740.95
AlogP:
5.88
PSA:
174.37
HBD:
5.0
HBA:
#RotB:
17.0
Source:
SERDEXMETHYLPHENIDATE
(2021)
Small molecule
Unknown
Unknown
Approved
Unknown
SERDEXMETHYLPHENIDATE
×
Maximum Phase:
4
First Approval:
2021
UNII:
0H8KZ470DW
Molecule Type:
Small molecule
Molecular Formula:
C25H30N3O8+
Molecular Weight:
500.53
AlogP:
1.05
PSA:
146.35
HBD:
3.0
HBA:
#RotB:
9.0
Source:
MOBOCERTINIB SUCCINATE
(2021)
Small molecule
Unknown
Unknown
Approved
Carcinoma, Non-Small-Cell Lung
MOBOCERTINIB SUCCINATE
×
Maximum Phase:
4
First Approval:
2021
UNII:
53QIA92ZEE
Molecule Type:
Small molecule
Molecular Formula:
C36H45N7O8
Molecular Weight:
703.8
AlogP:
5.08
PSA:
113.85
HBD:
2.0
HBA:
#RotB:
12.0
Source:
IBREXAFUNGERP CITRATE
(2021)
Small molecule
1,3-beta-glucan synthase inhibitor
Unknown
Approved
Candidiasis, Vulvovaginal
IBREXAFUNGERP CITRATE
×
Maximum Phase:
4
First Approval:
2021
UNII:
M4NU2SDX3E
Molecule Type:
Small molecule
Molecular Formula:
C50H75N5O11
Molecular Weight:
922.17
AlogP:
8.62
PSA:
125.38
HBD:
2.0
HBA:
#RotB:
8.0
Source:
EPHEDRINE HYDROCHLORIDE
(2021)
Small molecule
Adrenergic receptor agonist
Unknown
Approved
Hypotension
EPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2021
UNII:
NLJ6390P1Z
Molecule Type:
Small molecule
Molecular Formula:
C10H16ClNO
Molecular Weight:
201.7
AlogP:
1.33
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CABOTEGRAVIR
(2021)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
Unknown
Investigational
HIV Infections; Virus Diseases
CABOTEGRAVIR
×
Maximum Phase:
4
First Approval:
2021
UNII:
HMH0132Z1Q
Molecule Type:
Small molecule
Molecular Formula:
C19H17F2N3O5
Molecular Weight:
405.36
AlogP:
0.96
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SAMIDORPHAN
(2021)
Small molecule
Mu opioid receptor antagonist
Unknown
Investigational
Unknown
SAMIDORPHAN
×
Maximum Phase:
4
First Approval:
2021
UNII:
7W2581Z5L8
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O4
Molecular Weight:
370.45
AlogP:
1.25
PSA:
103.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AVACOPAN
(2021)
Small molecule
C5a anaphylatoxin chemotactic receptor antagonist
Unknown
Approved
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatosis with Polyangiitis; Microscopic Polyangiitis
AVACOPAN
×
Maximum Phase:
4
First Approval:
2021
UNII:
O880NM097T
Molecule Type:
Small molecule
Molecular Formula:
C33H35F4N3O2
Molecular Weight:
581.65
AlogP:
8.05
PSA:
61.44
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TIVOZANIB HYDROCHLORIDE
(2021)
Small molecule
Platelet-derived growth factor receptor beta inhibitor
Unknown
Investigational
Carcinoma, Renal Cell
TIVOZANIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2021
UNII:
8A9H4VK35Z
Molecule Type:
Small molecule
Molecular Formula:
C22H22Cl2N4O6
Molecular Weight:
509.35
AlogP:
5.64
PSA:
107.74
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VERICIGUAT
(2021)
Small molecule
Soluble guanylate cyclase activator
Unknown
Approved
Cardiovascular Diseases; Heart Failure
VERICIGUAT
×
Maximum Phase:
4
First Approval:
2021
UNII:
LV66ADM269
Molecule Type:
Small molecule
Molecular Formula:
C19H16F2N8O2
Molecular Weight:
426.39
AlogP:
2.56
PSA:
146.86
HBD:
3.0
HBA:
#RotB:
4.0
Source:
PAFOLACIANINE SODIUM
(2021)
Small molecule
Unknown
Unknown
Approved
Multiple Sclerosis
PAFOLACIANINE SODIUM
×
Maximum Phase:
4
First Approval:
2021
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTETROL
(2021)
Small molecule
Estrogen receptor agonist
Unknown
Approved
Pregnancy
ESTETROL
×
Maximum Phase:
4
First Approval:
2021
UNII:
ENB39R14VF
Molecule Type:
Small molecule
Molecular Formula:
C18H24O4
Molecular Weight:
304.39
AlogP:
1.55
PSA:
80.92
HBD:
4.0
HBA:
#RotB:
0.0
Source:
MELPHALAN FLUFENAMIDE
(2021)
Small molecule
Unknown
Unknown
Approved
Neoplasms
MELPHALAN FLUFENAMIDE
×
Maximum Phase:
4
First Approval:
2021
UNII:
F70C5K4786
Molecule Type:
Small molecule
Molecular Formula:
C24H30Cl2FN3O3
Molecular Weight:
498.43
AlogP:
3.27
PSA:
84.66
HBD:
2.0
HBA:
#RotB:
13.0
Source:
FINGOLIMOD LAURYL SULFATE
(2021)
Small molecule
Unknown
Unknown
Approved
Unknown
FINGOLIMOD LAURYL SULFATE
×
Maximum Phase:
4
First Approval:
2021
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEXINIDAZOLE
(2021)
Small molecule
Cytotoxic
Unknown
Approved
Leishmaniasis; Trypanosomiasis; Trypanosomiasis, African
FEXINIDAZOLE
×
Maximum Phase:
4
First Approval:
2021
UNII:
306ERL82IR
Molecule Type:
Small molecule
Molecular Formula:
C12H13N3O3S
Molecular Weight:
279.32
AlogP:
2.63
PSA:
70.19
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MARIBAVIR
(2021)
Small molecule
Phosphotransferase pUL97 inhibitor
Unknown
Approved
Cytomegalovirus; Virus Diseases
MARIBAVIR
×
Maximum Phase:
4
First Approval:
2021
UNII:
PTB4X93HE1
Molecule Type:
Small molecule
Molecular Formula:
C15H19Cl2N3O4
Molecular Weight:
376.24
AlogP:
1.77
PSA:
99.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
IBREXAFUNGERP
(2021)
Small molecule
1,3-beta-glucan synthase inhibitor
Unknown
Approved
Unknown
IBREXAFUNGERP
×
Maximum Phase:
4
First Approval:
2021
UNII:
A92JFM5XNU
Molecule Type:
Small molecule
Molecular Formula:
C44H67N5O4
Molecular Weight:
730.05
AlogP:
8.62
PSA:
125.38
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SAMIDORPHAN L-MALATE
(2021)
Small molecule
Delta opioid receptor partial agonist
Unknown
Approved
Bipolar Disorder; Schizophrenia
SAMIDORPHAN L-MALATE
×
Maximum Phase:
4
First Approval:
2021
UNII:
0AJQ5N56E0
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O9
Molecular Weight:
504.54
AlogP:
1.25
PSA:
103.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PONESIMOD
(2021)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 agonist
Unknown
Approved
Immune System Diseases; Multiple Sclerosis
PONESIMOD
×
Maximum Phase:
4
First Approval:
2021
UNII:
5G7AKV2MKP
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClN2O4S
Molecular Weight:
460.98
AlogP:
4.27
PSA:
82.36
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VILOXAZINE HYDROCHLORIDE
(2021)
Small molecule
Norepinephrine transporter inhibitor
Unknown
Approved
Attention Deficit Disorder with Hyperactivity
VILOXAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2021
UNII:
OQW30I1332
Molecule Type:
Small molecule
Molecular Formula:
C13H20ClNO3
Molecular Weight:
273.76
AlogP:
1.45
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BELUMOSUDIL MESYLATE
(2021)
Small molecule
Rho-associated protein kinase inhibitor
Unknown
Approved
Graft vs Host Disease
BELUMOSUDIL MESYLATE
×
Maximum Phase:
4
First Approval:
2021
UNII:
6MX7XE1M0U
Molecule Type:
Small molecule
Molecular Formula:
C27H28N6O5S
Molecular Weight:
548.63
AlogP:
4.82
PSA:
104.82
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FOSDENOPTERIN HYDROBROMIDE
(2021)
Small molecule
Unknown
Unknown
Approved
Metal Metabolism, Inborn Errors
FOSDENOPTERIN HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2021
UNII:
8Y2YH219A9
Molecule Type:
Small molecule
Molecular Formula:
C10H19BrN5O10P
Molecular Weight:
480.17
AlogP:
-2.52
PSA:
201.28
HBD:
7.0
HBA:
#RotB:
0.0
Source:
MOBOCERTINIB
(2021)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Approved
Unknown
MOBOCERTINIB
×
Maximum Phase:
4
First Approval:
2021
UNII:
39HBQ4A67L
Molecule Type:
Small molecule
Molecular Formula:
C32H39N7O4
Molecular Weight:
585.71
AlogP:
5.08
PSA:
113.85
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ASCIMINIB
(2021)
Small molecule
Tyrosine-protein kinase ABL inhibitor
Unknown
Approved
Neoplasms
ASCIMINIB
×
Maximum Phase:
4
First Approval:
2021
UNII:
L1F3R18W77
Molecule Type:
Small molecule
Molecular Formula:
C20H18ClF2N5O3
Molecular Weight:
449.85
AlogP:
3.46
PSA:
103.37
HBD:
3.0
HBA:
#RotB:
6.0
Source:
1
2
…
72
73
74
75
76
77
78
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA